How a New Leukemia Drug Undermines Cancer Cells (VIDEO)

Cold Spring Harbor Laboratory

Caption

CSHL Associate Prof. Christopher Vakoc explains how a very unimpressive protein performs 4 functions essential to the survival of the cancerous cells in the often fatal blood cancer, AML. A drug called JQ1 now in clinical trials undermines this protein, called NSD3-short.

Credit

Brian Stallard, CSHL

Usage Restrictions

please give credit

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.